Adrien Lanotte

Adrien Lanotte is a founding partner of the firm and a member of the M&A team.

For more than 15 years, he has been advising high-potential innovative companies as well as venture and tech growth investors on all their corporate equity and M&A transactions in Belgium and globally. As such, he is involved in every stage of their development, from incubation and fundraising to external growth and industrial exits as well as public offerings (IPO, secondary).

Adrien has extensive experience with M&A transactions, capital raises, joint ventures, mergers and other complex transactions. He also deals with issues in the various fields of business law such as contract negotiation, governance issues as well as relations between shareholders.

In addition to his skills in company law, Adrien has developed specific expertise in the matter of incentive schemes and, in this context, supports companies in the implementation of stock option plans or other schemes.

Adrien was admitted to the Brussels Bar in 2006. He joined Harvest in 2020 as a founding member. Previously, he worked in the Corporate and M&A department of CMS Belgium.

Adrien is a member of the Association of Lawyers in Stock Market and Financial Law.

 

Experience:

-Harvest advised Esobiotec, a biotechnology company pioneering in vivo cell therapies, on its agreement to be acquired by AstraZeneca for up to $ 1 billion on a cash and debt-free basis.

-Harvest advised some shareholders of Cluepoints in its sale to EQT Group.

-Harvest assisted Biocsol, an agritech company, in its € 10 million Series A round subscribed by AIF, Vives and Pymwymic funds.

-Harvest assisted RTL Group in its restructuring in Belgium and Luxembourg after its acquisition by Rossel and DPG Media.

-Harvest assisted Trustup in its Series A financing round subscribed by Rise Proptech Fund, Strada Partners and Brick & Mortar.

-Harvest assisted, alongside with Orrick, Cowboy’s investors in an $ 80 million Series C and $ 23 million Series B financing rounds.

-Harvest assisted IbanFirst in its € 200 million team up with Marlin Equity Partners.

-Harvest assisted Celyad, a Belgian biotechnology company listed on Euronext, in several private placements for a total of more than € 100 million.